$SERV
Serve Robotics Inc. /DE/

2023 Q3 Form 10-Q Financial Statement

#000121390023060310 Filed on July 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $62.57K
YoY Change
Cost Of Revenue $572.5K $758.6K
YoY Change 67.65%
Gross Profit -$510.0K -$656.4K
YoY Change 65.48%
Gross Profit Margin -815.11%
Selling, General & Admin $1.547M $3.464M
YoY Change 1054.93%
% of Gross Profit
Research & Development $2.963M $4.209M
YoY Change -9.17%
% of Gross Profit
Depreciation & Amortization $465.6K $931.3K
YoY Change
% of Gross Profit
Operating Expenses $5.068M $7.672M
YoY Change 1.03%
Operating Profit -$5.578M -$17.84K -$19.19K
YoY Change 41509.76% -7.04% 34.35%
Interest Expense $1.483M -$1.776M
YoY Change 4248.59%
% of Operating Profit
Other Income/Expense, Net -$2.068M -$864.6K
YoY Change 5962.92%
Pretax Income -$7.646M -$10.10M
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$7.646M -$17.84K -$19.19K
YoY Change 56938.21% -7.04% 34.35%
Net Earnings / Revenue -12220.85%
Basic Earnings Per Share -$0.41 $0.00 $0.00
Diluted Earnings Per Share -$0.41 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 5.000M shares 5.000M shares 5.000M shares
Diluted Shares Outstanding 18.53M shares 5.000M shares 5.000M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.502M $18.91K
YoY Change
Cash & Equivalents $3.502M $9.236K $2.673K
Short-Term Investments
Other Short-Term Assets $750.1K $417.7K
YoY Change
Inventory $868.7K $623.0K
Prepaid Expenses $750.1K
Receivables $3.955K $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $5.125M $9.236K $2.673K
YoY Change 404070.98% 245.53%
LONG-TERM ASSETS
Property, Plant & Equipment $1.982M $3.449M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $512.7K $512.7K
YoY Change
Total Long-Term Assets $3.389M $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $5.125M $9.236K $2.673K
Total Long-Term Assets $3.389M $0.00 $0.00
Total Assets $8.514M $9.236K $2.673K
YoY Change 671325.47% 245.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $944.5K $10.60K $10.00K
YoY Change 9344.87% 6.0%
Accrued Expenses $159.6K $620.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $151.5K $2.991M
YoY Change
Long-Term Debt Due $3.082M $3.271M
YoY Change
Total Short-Term Liabilities $4.856M $162.1K $101.9K
YoY Change 4162.24% 59.02%
LONG-TERM LIABILITIES
Long-Term Debt $813.9K $1.411M
YoY Change
Other Long-Term Liabilities $474.6K $17.61M
YoY Change
Total Long-Term Liabilities $1.288M $19.02M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.856M $162.1K $101.9K
Total Long-Term Liabilities $1.288M $19.02M
Total Liabilities $6.145M $162.1K $101.9K
YoY Change 5293.08% 59.02%
SHAREHOLDERS EQUITY
Retained Earnings -$61.27M -$153.4K -$99.77K
YoY Change 54039.71% 53.72%
Common Stock $2.436K $500.00 $500.00
YoY Change 387.2% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.369M -$152.9K -$99.27K
YoY Change
Total Liabilities & Shareholders Equity $8.514M $9.236K $2.673K
YoY Change 671325.47% 245.53%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$7.646M -$17.84K -$19.19K
YoY Change 56938.21% -7.04% 34.35%
Depreciation, Depletion And Amortization $465.6K $931.3K
YoY Change
Cash From Operating Activities -$5.704M -$6.590M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $2.490K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$2.490K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.190M 3.893M
YoY Change
NET CHANGE
Cash From Operating Activities -5.704M -6.590M
Cash From Investing Activities -2.490K 0.000
Cash From Financing Activities 9.190M 3.893M
Net Change In Cash 3.483M -2.697M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$5.704M -$6.590M
Capital Expenditures $2.490K $0.00
Free Cash Flow -$5.707M -$6.590M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Revenues
Revenues
usd
CY2022Q2 us-gaap Revenues
Revenues
usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5000000 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56237
dei Entity Registrant Name
EntityRegistrantName
Patricia Acquisition Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3844872
dei Entity Address Address Line1
EntityAddressAddressLine1
2255 Glades Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 324A
dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33431
dei City Area Code
CityAreaCode
(561)
dei Local Phone Number
LocalPhoneNumber
989-2208
dei Security12b Title
Security12bTitle
N/A
dei Trading Symbol
TradingSymbol
N/A
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5000000 shares
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9236 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
457 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
9236 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
457 usd
CY2023Q2 us-gaap Assets
Assets
9236 usd
CY2022Q4 us-gaap Assets
Assets
457 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10600 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
151500 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
114000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
162100 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
124000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
162100 usd
CY2022Q4 us-gaap Liabilities
Liabilities
124000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5000000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
500 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
500 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-153364 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124043 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-152864 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-123543 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9236 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
457 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17839 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19190 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29321 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27078 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17839 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19190 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-29321 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-27078 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-17839 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19190 usd
us-gaap Net Income Loss
NetIncomeLoss
-29321 usd
us-gaap Net Income Loss
NetIncomeLoss
-27078 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-72189 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-7888 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-80077 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19190 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-99267 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-123543 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11482 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-135025 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-17839 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-152864 usd
us-gaap Net Income Loss
NetIncomeLoss
-29321 usd
us-gaap Net Income Loss
NetIncomeLoss
-27078 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
600 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2500 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28721 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24578 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
37500 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
26980 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26980 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8779 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2402 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
457 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
271 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9236 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2673 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1. <span style="text-decoration:underline">Nature of Operations</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patricia Acquisition Corp. (the “Company”) was incorporated in the State of Delaware on November 9, 2020. The Company’s management has chosen December 31st for its fiscal year end.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly traded corporation. The Company’s principal business objective is to achieve long-term growth potential through a combination with a business, rather than immediate short-term earnings. The Company will not restrict its potential target companies to any specific business, industry, or geographical location. The analysis of business opportunities will be undertaken by, or under the supervision of, the officer and directors of the Company.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5000000 shares
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
28400 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22300 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
135000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
106000 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21 pure
CY2023Q2 us-gaap Derivative Variable Interest Rate
DerivativeVariableInterestRate
0.18 pure
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
151500 usd
CY2022 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
114000 usd
patr Going Concern
GoingConcern
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 6. <span style="text-decoration:underline">Going Concern</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has accumulated deficit and total stockholders’ deficit of $153,364 and $152,864, respectively, as of June 30, 2023. Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the date these financial statements are issued. Management intends to finance operations over the next twelve months through additional borrowings on the existing Note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.</p>
CY2023Q2 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
153364 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
152864 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Security Exchange Name
SecurityExchangeName
NONE
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5000000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001832483

Files In Submission

Name View Source Status
0001213900-23-060310-index-headers.html Edgar Link pending
0001213900-23-060310-index.html Edgar Link pending
0001213900-23-060310.txt Edgar Link pending
0001213900-23-060310-xbrl.zip Edgar Link pending
f10q0623ex31-1_patricia.htm Edgar Link pending
f10q0623ex32-1_patricia.htm Edgar Link pending
f10q0623_patriciaacq.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
patr-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
patr-20230630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
patr-20230630_def.xml Edgar Link unprocessable
patr-20230630_lab.xml Edgar Link unprocessable
patr-20230630_pre.xml Edgar Link unprocessable
f10q0623_patriciaacq_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending